• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Fate of Mycobacterium tuberculosis in mouse tissues as determined by the microbial enumeration technique. I. The persistence of drug-susceptible tubercle bacilli in the tissues despite prolonged antimicrobial therapy.通过微生物计数技术测定小鼠组织中结核分枝杆菌的命运。I. 尽管进行了长时间的抗菌治疗,组织中仍存在对药物敏感的结核杆菌。
J Exp Med. 1956 Nov 1;104(5):737-62. doi: 10.1084/jem.104.5.737.
2
The fate of Mycobacterium tuberculosis in mouse tissues as determined by the microbial enumeration technique. II. The conversion of tuberculous infection to the latent state by the administration of pyrazinamide and a companion drug.通过微生物计数技术确定结核分枝杆菌在小鼠组织中的命运。II. 给予吡嗪酰胺和一种辅助药物使结核感染转变为潜伏状态。
J Exp Med. 1956 Nov 1;104(5):763-802. doi: 10.1084/jem.104.5.763.
3
RESISTANT tubercle bacilli.耐药结核杆菌
Lancet. 1957 Apr 20;272(6973):825-6.
4
Pyrazinamide together with oxytetracycline in patients with tubercle bacilli resistant to streptomycin, PAS and isoniazid.对链霉素、对氨基水杨酸和异烟肼耐药的结核杆菌患者使用吡嗪酰胺联合土霉素。
Br J Tuberc Dis Chest. 1957 Apr;51(2):158-67. doi: 10.1016/s0366-0869(57)80031-8.
5
[EFFECTS OF ETHIONAMIDE ON TUBERCLE BACILLI RESISTANT TO VARIOUS ANTITUBERCULAR AGENTS AND THE EFFECTS OF THESE AGENTS ON ETHIONAMIDE-RESISTANT TUBERCLE BACILLI].[乙硫异烟胺对耐各种抗结核药物的结核杆菌的作用以及这些药物对耐乙硫异烟胺结核杆菌的作用]
Kekkaku. 1963 Jun;38:264-9.
6
LABORATORY techniques for the determination of sensitivity of tubercle bacilli to isoniazid, streptomycin, and P.A.S.测定结核杆菌对异烟肼、链霉素和对氨基水杨酸敏感性的实验室技术
Lancet. 1953 Aug 1;265(6779):213-7.
7
[PRIMARY DRUG RESISTANCE OF TUBERCLE BACILLI TO BASIC ANTIMICROBIAL DRUGS].[结核杆菌对基本抗微生物药物的原发性耐药性]
Gruzlica (1926). 1963 May;31:387-95.
8
The chemotherapeutic agents and their resistance against tubercle bacilli. III. Hemin starch liquid medium for the cultivation of isoniazid-susceptible and resistant tubercle bacilli.化疗药物及其对结核杆菌的耐药性。III. 用于培养对异烟肼敏感和耐药结核杆菌的血红素淀粉液体培养基。
Sci Rep Res Inst Tohoku Univ Med. 1955 Oct;6(3):377-90.
9
[Study on infection with drug resistant tubercle bacilli from patients among the already tuberculin-positive persons without tuberculous lesions in a workshop].[某车间已结核菌素阳性但无结核病变者中患者耐药结核杆菌感染情况的研究]
Kekkaku. 1962 Apr;37:188-94.
10
Sensitivity to streptomycin, isoniazid and para-aminosalicylic acid of tubercle bacilli from patients with pulmonary tuberculosis in Sri Lanka.斯里兰卡肺结核患者结核杆菌对链霉素、异烟肼和对氨基水杨酸的敏感性
Ceylon Med J. 1982 Jun;27(2):69-74.

引用本文的文献

1
Priestia megaterium cells are primed for surviving lethal doses of antibiotics and chemical stress.巨大芽孢杆菌细胞能够在致死剂量的抗生素和化学应激下存活。
Commun Biol. 2025 Feb 8;8(1):206. doi: 10.1038/s42003-025-07639-2.
2
Noncanonical roles of ATG5 and membrane atg8ylation in retromer assembly and function.ATG5的非经典作用及膜型自噬相关蛋白8脂化在Retromer复合体组装与功能中的作用
Elife. 2025 Jan 7;13:RP100928. doi: 10.7554/eLife.100928.
3
Noncanonical roles of ATG5 and membrane atg8ylation in retromer assembly and function.自噬相关蛋白5(ATG5)的非经典作用及膜型自噬相关蛋白8(Atg8)脂化在回收体组装和功能中的作用
bioRxiv. 2024 Oct 14:2024.07.10.602886. doi: 10.1101/2024.07.10.602886.
4
Pyrazinamide Safety, Efficacy, and Dosing for Treating Drug-Susceptible Pulmonary Tuberculosis: A Phase 3, Randomized Controlled Clinical Trial.吡嗪酰胺治疗药物敏感肺结核的安全性、疗效和剂量:一项 3 期随机对照临床试验。
Am J Respir Crit Care Med. 2024 Dec 1;210(11):1358-1369. doi: 10.1164/rccm.202401-0165OC.
5
Isolation and characterization of persisters of the pathogenic microorganism .致病微生物持留菌的分离与鉴定
iScience. 2024 May 16;27(6):110002. doi: 10.1016/j.isci.2024.110002. eCollection 2024 Jun 21.
6
Gallein potentiates isoniazid's ability to suppress growth.镓试剂增强了异烟肼抑制生长的能力。
Front Microbiol. 2024 Apr 15;15:1369763. doi: 10.3389/fmicb.2024.1369763. eCollection 2024.
7
Gallein and isoniazid act synergistically to attenuate growth in human macrophages.镓试剂和异烟肼协同作用,可抑制人类巨噬细胞的生长。
bioRxiv. 2024 Jan 10:2024.01.10.574965. doi: 10.1101/2024.01.10.574965.
8
Design, Synthesis, and Evaluation of Novel Δ-Thiazolino 2-Pyridone Derivatives That Potentiate Isoniazid Activity in an Isoniazid-Resistant Mutant.新型 Δ-噻唑啉-2-吡啶酮衍生物的设计、合成与评价及其对异烟肼耐药突变体的增效作用。
J Med Chem. 2023 Aug 24;66(16):11056-11077. doi: 10.1021/acs.jmedchem.3c00358. Epub 2023 Jul 24.
9
The past, present and future of tuberculosis treatment.结核病治疗的过去、现在和未来。
Zhejiang Da Xue Xue Bao Yi Xue Ban. 2022 Dec 25;51(6):657-668. doi: 10.3724/zdxbyxb-2022-0454.
10
Molecular Mechanisms of MmpL3 Function and Inhibition.MmpL3 功能和抑制的分子机制。
Microb Drug Resist. 2023 May;29(5):190-212. doi: 10.1089/mdr.2021.0424. Epub 2023 Feb 21.

本文引用的文献

1
Nonautomatic pipetting devices for the microbiologic laboratory.微生物实验室用非自动移液装置。
J Lab Clin Med. 1950 Apr;35(4):648-51.
2
Pyrazinamide (aldinamide) in the treatment of pulmonary tuberculosis.吡嗪酰胺(氨甲酰吡嗪)治疗肺结核
Am Rev Tuberc. 1952 May;65(5):523-46.
3
The fate of Mycobacterium tuberculosis in mouse tissues as determined by the microbial enumeration technique. II. The conversion of tuberculous infection to the latent state by the administration of pyrazinamide and a companion drug.通过微生物计数技术确定结核分枝杆菌在小鼠组织中的命运。II. 给予吡嗪酰胺和一种辅助药物使结核感染转变为潜伏状态。
J Exp Med. 1956 Nov 1;104(5):763-802. doi: 10.1084/jem.104.5.763.
4
The influence of pyrazinamide-isoniazid on M. tuberculosis in animals and man.吡嗪酰胺-异烟肼对动物及人体中结核分枝杆菌的影响。
Trans Assoc Am Physicians. 1954;67:224-31.
5
Pyrazinamide-isoniazid in tuberculosis.吡嗪酰胺-异烟肼治疗结核病
Am Rev Tuberc. 1954 Mar;69(3):319-33. doi: 10.1164/art.1954.69.3.319.

通过微生物计数技术测定小鼠组织中结核分枝杆菌的命运。I. 尽管进行了长时间的抗菌治疗,组织中仍存在对药物敏感的结核杆菌。

Fate of Mycobacterium tuberculosis in mouse tissues as determined by the microbial enumeration technique. I. The persistence of drug-susceptible tubercle bacilli in the tissues despite prolonged antimicrobial therapy.

作者信息

MCCUNE R M, TOMPSETT R

出版信息

J Exp Med. 1956 Nov 1;104(5):737-62. doi: 10.1084/jem.104.5.737.

DOI:10.1084/jem.104.5.737
PMID:13367341
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2136613/
Abstract

Observations are presented on the behavior of populations of tubercle bacilli in the tissues of mice during the administration of antimicrobial drugs. The behavior of the populations during therapy with any particular drug was different depending upon whether the tubercle bacilli were subsisting in the lung or in the spleen. Moreover, the pattern of microbial behavior was distinctive and predictable for each drug studied. Changes in the size of the populations of tubercle bacilli in the tissues appeared to be a more sensitive reflection of drug influence than microscopic study of the number and character of the tuberculous lesions. Nevertheless, in untreated animals, pulmonary lesions evolved and progressed steadily to a fatal outcome despite the fact that the populations of tubercle bacilli had stabilized at a relatively high census early in the course of therapy. The uniform persistence of tubercle bacilli in the spleen throughout prolonged drug administration was demonstrated with every drug or multiple drug regimens except for pyrazinamide when accompanied by isoniazid. Cultures of the bacilli which survived in the tissues despite antimicrobial therapy were highly susceptible to the drugs employed when tested in vitro. Thus the survival of the tubercle bacilli in the tissues represented microbial persistence rather than drug resistance. When pyrazinamide and isoniazid were administered together, it was not possible to detect the microorganisms in the spleen or lungs of treated animals. A detailed investigation of this apparent abolition of microbial persistence forms the subject of an accompanying report.

摘要

本文呈现了在给予抗菌药物期间,结核杆菌群体在小鼠组织中的行为观察结果。在使用任何一种特定药物治疗期间,结核杆菌群体的行为因它们存在于肺部还是脾脏而有所不同。此外,对于所研究的每种药物,微生物行为模式都是独特且可预测的。与对结核病变的数量和特征进行显微镜研究相比,组织中结核杆菌群体大小的变化似乎更能敏感地反映药物的影响。然而,在未经治疗的动物中,尽管在治疗早期结核杆菌群体已稳定在相对较高的数量,但肺部病变仍持续发展并最终导致致命结果。除了吡嗪酰胺与异烟肼联用时外,在长期给予每种药物或多种药物治疗方案的过程中,脾脏中的结核杆菌始终持续存在。尽管接受了抗菌治疗,但在组织中存活下来的杆菌培养物在体外测试时对所用药物高度敏感。因此,组织中结核杆菌的存活代表的是微生物的持续存在而非耐药性。当同时给予吡嗪酰胺和异烟肼时,在接受治疗的动物的脾脏或肺部中无法检测到微生物。对这种明显消除微生物持续存在现象的详细研究构成了一篇配套报告的主题。